
        <!DOCTYPE html>
    <html lang="ja">
    <style>
    body
    {
        color: black;
        background-color: white;
    }
    div{
        font-size: 14px;
    }
    span
    {
        font-size: 18px;
    }
    #grad1{
        background: linear-gradient(transparent 60%,#99e4f1 30%);
        font-size: 18px;
        font-weight: bold;
    }
    #grad2{
        background: linear-gradient(transparent 60%,#fda1a1 30%);
        font-size: 18px;
        font-weight: bold;
    }

    </style>

    <head>
        <meta charset="UTF-8">
        <title>103-256</title>
    </head>

    <body>
        <h1>
        <a href="./103_255.html" rel="external" title="prev">≪</a>
        103-256
        <a href="./103_257.html" rel="external" title="next">≫</a>
        </h1>
        <div class='problem'>
            <p>
                <span id="grad1">　問題文　</span>
            </p>
            <p>
                <p>50歳女性。頻尿、排尿痛があり泌尿器科を受診し、尿道炎と診断され処方(処方1)が出された。同日、歯科にて抜歯し処方(処方2)が出され、近くの薬局にて処方1と2の薬を受け取った。</p>
<p>4日後薬局に電話をかけ、「もらった薬は決められたように飲んでいる。痛み止めは昨日まで7回飲んだ。昨日から太ももが痛く、今日は、手足がだるく、足に力が入らず歩けないため仕事を休んだ。このまま薬を服用していいか。」と相談した。</p>
<p>来局時、お薬手帳は持参しておらず、聞き取りでは「薬の名前は覚えていないが、他の薬局でもらった骨の薬と、コレステロールの薬と、胃薬を飲んでいる。」とのことであった。</p>
<p>そこで、薬剤師が電話口でこの女性にお薬手帳を確認してもらったところ、1年ほど前から他の薬局にて調剤された薬剤を継続服用していることが明らかになった。薬剤師は薬物相互作用を疑い、直ちに処方医に連絡をした。</p>
<p><img alt="" class="alignnone size-full wp-image-3254" height="240.79999999999998" loading="lazy" sizes="(max-width: 673px) 100vw, 673px" src="data:;base64,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" width="471.09999999999997"/></p>
<h4>問256</h4>
<p>次の作用様式のうち、この患者が服用した5つの薬物のいずれかの作用機序に当てはまるのはどれか。2つ選べ。</p>
<ol><li>核内受容体刺激</li><li>Gタンパク共役型受容体遮断</li><li>DNA複製阻害</li><li>細菌のリボソームでのタンパク質合成阻害</li><li>タンパク分解酵素阻害</li></ol>
<h4>問257</h4>
<p>薬剤師が薬物相互作用の原因と考えた薬剤はどれか。2つ選べ。</p>
<ol><li>アルファカルシドールカプセル</li><li>ポラプレジンク口腔内崩壊錠</li><li>シンバスタチン錠</li><li>クラリスロマイシン錠</li><li>ロキソプロフェンナトリウム水和物錠</li></ol>    
            </p>
        </div>
        <hr>

        <input type="button" value="check ans" onclick="toggle_switch()"/>
        
        <div id='toggle'>
        <div class='answer'>
            <p>
                <span id="grad2">　解答　　</span>
            </p>
            <p>
            問256：1, 4問257：3, 4
            </p>
        </div>
        <div class='description'>
            <p>
                <span id="grad2">　解説　　</span>
            </p>
            <h4>問256</h4>
<p>問257 とまとめて解説します。</p>
<h4>問257</h4>
<p><span style="font-weight: 400;">クラリスロマイシンは</span><span style="font-weight: 400;">マクロライド系抗生物質です。</span><span style="font-weight: 400;">タンパク合成阻害系の抗菌薬です。</span></p>
<p><span style="font-weight: 400;">ロキソプロフェンは</span><span style="font-weight: 400;">NSAIDs です。鎮痛薬です。</span></p>
<p><span style="font-weight: 400;">アルファカルシドールは</span><span style="font-weight: 400;">活性型ビタミン D</span><span style="font-weight: 400;">3</span><span style="font-weight: 400;"> 製剤です。</span><span style="font-weight: 400;">骨粗しょう症薬です。 </span><span style="font-weight: 400;">ビタミンD受容体は</span><span style="font-weight: 400;">核内受容体の一種です。</span></p>
<p><span style="font-weight: 400;">ポラプレジンク（プロマック）は</span><span style="font-weight: 400;">亜鉛含有胃潰瘍治療剤です。</span></p>
<p><span style="font-weight: 400;">シンバスタチンは</span><span style="font-weight: 400;">HMG-CoA 還元酵素阻害薬です。</span></p>
<p><span style="font-weight: 400;">女性の相談は、</span><span style="font-weight: 400;">横紋筋融解症の初期症状と考えられます。</span><span style="font-weight: 400;">クラリスロマイシンが、</span><span style="font-weight: 400;">CYP3A4 阻害するため</span><span style="font-weight: 400;">同酵素で代謝される</span><span style="font-weight: 400;">シンバスタチンの血中濃度を上昇させ</span><span style="font-weight: 400;">副作用リスクが上がることが知られています。</span></p>
<p><span style="font-weight: 400;">以上より、</span><span style="font-weight: 400;">問256 の正解は 1,4 です。<br/></span><span style="font-weight: 400;">問257 の正解は 3,4 です。</span></p>
            </p>
        </div>
        </div>
    </body>
    <script>
    document.getElementById("toggle").style.display="none";
    function toggle_switch(){
        var x = document.getElementById("toggle");
        if (x.style.display=="block"){
            x.style.display="none";
        }
        else{
            x.style.display="block";
        }
    }
    </script>
    